Nurix Therapeutics, Inc. Annual Return On Assets in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nurix Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2023.
  • Nurix Therapeutics, Inc. Return On Assets for the quarter ending May 31, 2024 was -44.4 %, a 12.5% decline year-over-year.
  • Nurix Therapeutics, Inc. annual Return On Assets for 2023 was -41.6 %, a 1.54% increase from 2022.
  • Nurix Therapeutics, Inc. annual Return On Assets for 2022 was -42.2 %, a 69.8% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -41.6 +0.65 +1.54% Dec 1, 2022 Nov 30, 2023
2022 -42.2 -17.4 -69.8% Dec 1, 2021 Nov 30, 2022
2021 -24.9 Dec 1, 2020 Nov 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.